Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
about
Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trialOxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settingsOxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settingsHomeopathy for reducing blood loss in the third stage of labourTranexamic acid for preventing postpartum haemorrhageActive versus expectant management for women in the third stage of labourUterotonic agents for preventing postpartum haemorrhage: a network meta-analysisThird Stage of Labor and AcupunctureOxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness AnalysisEvaluation of in vivo effects of Oxytocin on coagulation of parturient during cesarean delivery by thromboelastographyBarriers to deferred cord clamping in preterm infants.Oxytocin: taking the heat.Status of emergency obstetric care in six developing countries five years before the MDG targets for maternal and newborn health.The prevention of postpartum hemorrhage in the community.Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011Second-line uterotonics and the risk of hemorrhage-related morbidityStudy protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.Bedside Availability of Prepared Oxytocin and Rapid Administration After Delivery to Prevent Postpartum Hemorrhage: An Observational Study in Karnataka, India.Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.Use of prophylactic uterotonics during the third stage of labor: a survey of provider practices in community health facilities in Sierra Leone.Incidence of immediate postpartum hemorrhages in French maternity units: a prospective observational study (HERA study)Replacement of oxytocin bolus administration by infusion: influences on postpartum outcomeAcute complete uterine inversion after controlled cord traction of placenta following vaginal delivery: a case report.Management of obstetric postpartum hemorrhage: a national service evaluation of current practice in the UK.Understanding causal pathways within health systems policy evaluation through mediation analysis: an application to payment for performance (P4P) in TanzaniaRole of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth.Improving the quality of maternity services in Uganda through accelerated implementation of essential interventions by healthcare professional associations.The association between the time from oxytocin cessation during labour to Cesarean delivery and postpartum blood loss: a retrospective cohort study.Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year.Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.Effects of placental cord drainage in the third stage of labour: A meta-analysis.The Routine Use of Prophylactic Oxytocin in the Third Stage of Labor to Reduce Maternal Blood Loss.Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit.Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial
P2860
Q21144590-F46F0434-5DED-4672-90BC-5F8B5766DD62Q24185904-8AD9EAAA-B4A4-4506-A8E3-A241C6C030CFQ24186371-75686FE6-B1A7-4473-A43C-974B0CD8E503Q24186919-60C2EEF4-EC6C-41F5-9106-5F3335620845Q24187146-397C07BC-C268-4E1A-9B55-6CC963944AE7Q24187465-207F98CF-FBD5-4CD5-9D33-DBA1E3E46010Q24188230-35ABD169-9F6B-4ABC-BD02-2D43D3DEF51FQ26866389-A2469222-348B-47AF-96D4-1C588A9076DDQ29353660-6A1612AD-9830-44BD-A337-558C77407834Q33834262-35E6B369-6199-4509-A155-28D5321F0185Q34092317-538BC514-9C9E-4358-93DB-E8C99FC138EDQ34210947-D14B37BF-4D8D-49CB-ACD5-0F93B1A91A57Q34510283-FA963A5D-9C82-43B9-BABD-13BED7C23BE0Q35018000-CB0653CA-783E-470D-A295-31385815093EQ35064648-92371DE1-4799-4A61-A75F-A1844F16DE3CQ35561431-D2C31331-0DD2-4A71-8353-10FF2E4861FFQ35662691-849AFE46-D28E-459F-8BA9-54AE3C91D114Q35767820-D6397762-E600-42EA-902A-0F78578677AEQ35839057-01AFC71D-C547-4612-BF62-1826D4969067Q35907466-B6B7FD3A-230A-4BD7-BDD4-B2DDDB3C488EQ36110591-50C204F4-B6DF-46A8-A5B7-6A3C105A0B66Q36892289-8DFD5FA8-50F6-42E1-BF9C-C2D6D45AAC89Q37057894-531696A9-F80E-4615-B8EA-43857456E342Q37603672-EA9B1C7D-1A17-496A-888F-C8B1E9AFB403Q37620897-15E3025C-B54F-449A-9714-D9754BFC82C2Q38681098-EC9A69B6-1445-4B88-8DCE-126CEA99B494Q38717153-DBC431AD-50D7-4369-A9E5-D5C053F4238DQ38831096-934CA2AF-5825-46DF-B1B5-97972778AB80Q38992677-3A6951BB-B301-45B2-A005-68E4EA82C5DCQ39204770-87D88ECC-8906-44FD-8012-8AC008C149F5Q40117688-B987839B-2753-4D11-8A5A-B908A55DFAB1Q41203561-A17571AB-4E8E-4230-95A5-433AD92F1B2FQ42729169-C850AB18-870E-4F95-9E7C-BB5C11817AE1Q46301140-BA543D34-8F86-41A6-A954-D54FF690A71CQ46301463-07EA9F1B-12B2-4ADB-B3D1-B97C37A3EEF5Q46364343-E8C92B66-9E54-42DC-9B74-6352FBD4E2EBQ47805495-0968FDDA-F9A9-4BA5-B6C5-646CC250470BQ58765740-F0902B54-7246-46A4-8B9C-510981F35083
P2860
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@ast
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en-gb
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@nl
type
label
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@ast
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en-gb
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@nl
prefLabel
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@ast
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en-gb
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@nl
P2093
P2860
P921
P3181
P1476
Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage
@en
P2093
Amanda M Cotter
Gina Westhoff
Jorge E Tolosa
P2860
P304
P3181
P356
10.1002/14651858.CD001808.PUB2
P407
P577
2013-10-30T00:00:00Z